Novolog side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Novolog. Common side effects include blood glucose increased among females, and blood glucose increased among males.
The phase IV clinical study is created by eHealthMe based on 53,713 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53,713 people who take Novolog and have side effects are studied.
What is Novolog?
Novolog has active ingredients of insulin aspart recombinant. It is used in diabetes. Currently, eHealthMe is studying from 54,194 Novolog users.
Number of Novolog reports submitted per year:
Novolog side effects by time on the drug *:
Novolog side effects by gender *:
Novolog side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Novolog?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on insulin aspart recombinant (the active ingredients of Novolog) and Novolog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Novolog:
- Novolog (54,194 reports)
Common Novolog side effects:
- Drug ineffective: 2,767 reports
- Fatigue (feeling of tiredness): 2,633 reports
- Breathing difficulty: 2,262 reports
- Diarrhea: 2,129 reports
- Chronic kidney disease: 2,035 reports
All Novolog side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rapaflo and Arimidex drug interaction - 20 seconds ago
- Temaz and Pancreatic Cyst - 21 seconds ago
- Liothyronine Sodium and Weight Abnormal - 41 seconds ago
- Didanosine and Gastroesophageal Reflux Disease - 41 seconds ago
- Loraz and Difficulty In Micturition - 55 seconds ago
- Vascepa and Osteoarthritis - 59 seconds ago
- Botox and Tooth Fracture - a minute ago
- Aspirin and Breast Calcifications - a minute ago
- Vicoprofen and Kidney Stones - a minute ago
- Clobetasol Propionate and Eyelid Margin Crusting - a minute ago